2026 Frameworx series
FrameWORX: Indiana as a Destination for Cancer Care
From groundbreaking research and clinical care to biomanufacturing and workforce development, this FrameWORX will showcase the full scope of Indiana’s capabilities in the fight against cancer. We’ll explore how cross-sector collaboration and strategic investment are fueling Indiana’s rise as a leader in cancer innovation, advancing prevention, diagnosis, treatment, and outcomes statewide.
Radiopharmaceuticals will be part of the conversation as well, highlighting how Indiana’s specialized manufacturing infrastructure, highly skilled talent, and unique logistics advantages are helping position our state as a national hub for cancer care and discovery.
Event Details
Date: Thursday, March 12
Location: Indiana Biosciences Research Institute (IBRI), 16 Tech Innovation District, Indianapolis
Time: 3 p.m. – 5:30 p.m.
The event is presented by:
FrameWORX Agenda
Opening Remarks
Vince Wong, President & CEO, BioCrossroads
Vince Wong
President and CEO
BioCrossroads
Indiana's Integrated Academic Research Ecosystem
An exploration of Indiana’s integrated academic cancer research ecosystem and how cross institutional collaboration accelerates discovery, enables clinical trials, and expands patient access through shared infrastructure, data, and emerging fields like radiopharmaceutical research.
Vince Wong - Moderator
President and CEO
BioCrossroads
Brian Blagg, PhD
Director, Warren Center for Drug Discovery and Development
Charles Huisking Professor of Chemestry and Biochemistry
University of Notre Dame
D. Wade Clapp, MD
Senior Associate Dean for Entrepreneurial Research and Commercialization
Distinguished Professor
Chair of Pediatrics
Indiana University School of Medicine
Kelvin Lee, MD
Associate Dean for Cancer Research
IU School of Medicine
Associate Director, IU Melvin and Bren Simon Comprehensive Cancer Center
Precision Medicine: From Genomics to Treatment Decisions
Precision medicine is changing how cancer is diagnosed and treated. This conversation explores how genomic data, diagnostics, and analytics are being used to guide treatment decisions in real clinical settings. The discussion will focus on how precision oncology works today, what has changed in recent years, and how tools like genomics and data integration are influencing care pathways and outcomes.
Vince Wong - Moderator
President and CEO
BioCrossroads
Milan Radovich, PhD
Senior Vice President and Chief Scientific Officer
Caris Life Sciences
Juan Perlaza
Director, Pathology Lab Assays and Companion Diagnostics
Roche Diagnostics
David Lahm
Associate Vice President, Global Diagnostics
Eli Lilly and Company
Chair, Board of Directors, Indiana Cancer Consortium
Fireside Chat: The Patient Perspective
The conversation highlights how access to advanced diagnostics, coordinated care, and timely treatment can shape outcomes, and why integration across research, diagnostics, and care delivery matters from the patient’s point of view.
Mike Bolinder - Moderator
Senior Vice President, External Engagement & Chief Innovation Officer
BioCrossroads
Radiopharmaceuticals, Indiana, and the Future of Precision Medicine
Radiopharmaceuticals are transforming cancer care by combining targeted therapies with advanced imaging and precision delivery. This panel examines how Indiana is building the research, manufacturing, clinical, and delivery capabilities required to advance radiopharmaceutical care at scale. Panelists will discuss research and development, manufacturing, clinical trials, patient access, and the infrastructure needed to support growth, as well as where the field is headed next.
Mike Bolinder - Moderator
Senior Vice President, External Engagement & Chief Innovation Officer
BioCrossroads
Matt Baca
Head of Site Operations, Indianapolis
Novartis
Sumit Verma
CEO, TAG1 inc.
Co-Founder and Partner
Orchestra Life Sciences
Guest from SpectronRX
